A promising medication , retatrutide, is sparking considerable interest in the field of weight management . This novel therapy, a dual -action receptor agonist, appears to affect both GLP-1 and GIP hormones, https://izaaketaf079207.blog5.net/93497803/retatrutide-the-new-weight-management-hope